NO983238D0 - Exodus kjemokin materialer og fremgangsmater - Google Patents

Exodus kjemokin materialer og fremgangsmater

Info

Publication number
NO983238D0
NO983238D0 NO983238A NO983238A NO983238D0 NO 983238 D0 NO983238 D0 NO 983238D0 NO 983238 A NO983238 A NO 983238A NO 983238 A NO983238 A NO 983238A NO 983238 D0 NO983238 D0 NO 983238D0
Authority
NO
Norway
Prior art keywords
materials
methods
exodus
chemokine
exodus chemokine
Prior art date
Application number
NO983238A
Other languages
English (en)
Other versions
NO983238L (no
Inventor
Robert Hromas
Original Assignee
Indiana University Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indiana University Foundation filed Critical Indiana University Foundation
Publication of NO983238D0 publication Critical patent/NO983238D0/no
Publication of NO983238L publication Critical patent/NO983238L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO983238A 1996-11-15 1998-07-14 Exodus kjemokin materialer og fremgangsmÕter NO983238L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74951396A 1996-11-15 1996-11-15
PCT/US1997/020662 WO1998021330A1 (en) 1996-11-15 1997-11-14 Exodus chemokine materials and methods

Publications (2)

Publication Number Publication Date
NO983238D0 true NO983238D0 (no) 1998-07-14
NO983238L NO983238L (no) 1998-09-15

Family

ID=25014053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983238A NO983238L (no) 1996-11-15 1998-07-14 Exodus kjemokin materialer og fremgangsmÕter

Country Status (14)

Country Link
US (1) US6096300A (no)
EP (1) EP0894134A1 (no)
JP (1) JP2001516203A (no)
CN (1) CN1213401A (no)
AU (1) AU5255398A (no)
BR (1) BR9707142A (no)
CA (1) CA2242384A1 (no)
CZ (1) CZ220298A3 (no)
HU (1) HUP0000316A2 (no)
IL (1) IL125351A0 (no)
NO (1) NO983238L (no)
PL (1) PL327853A1 (no)
SK (1) SK96398A3 (no)
WO (1) WO1998021330A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458349B1 (en) * 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
JP2002500509A (ja) 1997-04-30 2002-01-08 エフ．ホフマン−ラ ロシュ アーゲー ラットｓｔ３８．２ケモカイン
US20030144225A1 (en) * 2001-12-28 2003-07-31 Karras James G. Antisense modulation of macrophage inflammatory protein 3-alpha expression
AU6497799A (en) * 1998-10-15 2000-05-01 Canji, Inc. Methods and compositions to induce antitumor response
US6649158B1 (en) 1998-10-15 2003-11-18 Canji, Inc. Methods and compositions to induce antitumor response
AU2002228742A1 (en) * 2000-10-19 2002-04-29 Genaissance Pharmaceuticals, Inc. Haplotypes of the scya20 gene
EP1534752B1 (en) 2002-05-01 2011-08-03 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
EA029419B1 (ru) 2010-11-19 2018-03-30 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Нейтрализующие антитела против ccl20

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037630A (en) * 1985-01-14 1991-08-06 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5179078A (en) * 1989-05-12 1993-01-12 Dana Farber Cancer Institute Method of suppressing tumor formation in vivo
US5413778A (en) * 1992-10-05 1995-05-09 The Regents Of The University Of Michigan Labelled monocyte chemoattractant protein material and medical uses thereof
DE69433648T2 (de) * 1994-08-23 2005-02-17 Human Genome Sciences, Inc. Menschliche chemokin-polypeptide
US5602008A (en) * 1994-11-29 1997-02-11 Incyte Pharmaceuticals, Inc. DNA encoding a liver expressed chemokine
WO1998001557A2 (en) * 1996-07-05 1998-01-15 Schering Corporation Mammalian chemokine reagents

Also Published As

Publication number Publication date
HUP0000316A2 (en) 2000-07-28
AU5255398A (en) 1998-06-03
CN1213401A (zh) 1999-04-07
WO1998021330A1 (en) 1998-05-22
BR9707142A (pt) 1999-12-28
CZ220298A3 (cs) 1999-01-13
PL327853A1 (en) 1999-01-04
JP2001516203A (ja) 2001-09-25
SK96398A3 (en) 1999-04-13
US6096300A (en) 2000-08-01
IL125351A0 (en) 1999-03-12
CA2242384A1 (en) 1998-05-22
EP0894134A1 (en) 1999-02-03
NO983238L (no) 1998-09-15

Similar Documents

Publication Publication Date Title
IS4481A (is) Díhýdrópyramídín og notkun þeirra
DK0915880T3 (da) Azolotriaziner og pyrimidiner
NO983981D0 (no) Isolert vegg og tilhörende komponenter
NO984354D0 (no) Avisingsmiddel og anvendelse av dette
NO992297L (no) FremgangsmÕte og nye forbindelser
NO20011821D0 (no) Arbeidsromorganisering og möbelsystem
DE69734367D1 (de) Plattenstruktur und Reibschweissverfahren
DK0804078T3 (da) Sammensætning og anvendelse deraf
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
NO983238D0 (no) Exodus kjemokin materialer og fremgangsmater
NO955138D0 (no) Aktivert smektittleire, og fremstilling derav
NO984861D0 (no) Piperidiner og pyrrolidiner
NO964541L (no) Porphacyanin og CNC-utvidete porphyriner
NO985806L (no) Kitinasematerialer og fremgangsmÕter
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO983802D0 (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter
DE69515383D1 (de) Abtast- und Halteschaltung
FR2749049B1 (fr) Embrayage modulaire et sa structure
NO983556L (no) Formulering og anvendelse
FR2865535B1 (fr) Penetreur
FI931759A0 (fi) Kuorinta- ja haketuslaite
NO952766D0 (no) Opplösningsmiddelsammensetninger og metoder
DK1042286T3 (da) Gamme-glutamyl- og beta-aspartyl-holdige immunmodulerende forbindelser og tilhørense fremgangsmåder
DE59812220D1 (de) Halte- und trageband
BR7603138U (pt) Prática e única

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application